date:Jun 01, 2016
Nestl Health Science is collaborating with French technology company DBV Technologies to develop a patch-test tool for the diagnosis of cows milk protein allergy (CMPA) in infants.
Nestle cow milk protein
Under the partnership, DBV will offer its exclusive worldwide commercialization rights of DBV's diagnostic tool to Nestle.
Nestl will make an upfront payment of 10m. DBV will be in charge of development stages, including industrialization and regulatory submissions.
It will also qualify for r